Gilder Gagnon Howe & CO LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.87 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.2 - $4.2 $815,390 - $1.56 Million
-370,632 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.83 - $8.69 $1.09 Million - $3.36 Million
-386,564 Reduced 51.05%
370,632 $1.49 Million
Q4 2021

Feb 14, 2022
BUY
$8.31 - $14.92 $6.29 Million - $11.3 Million
757,196 New
757,196 $6.29 Million

Others Institutions Holding DNA

# of Institutions
33
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $18.4B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email